The mpox virus appears to be circulating silently in parts of Nigeria, in many cases without the symptoms typically ...
Based on the topline results from the EPCORE® DLBCL-1 trial, AbbVie along with partner Genmab will engage global regulatory authorities to discuss next steps NORTH ...
Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, which ...
A new discovery about how cells communicate with each other in the body's immune system has revealed deeper insights for an ...
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...
ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...
University of Illinois students created oPool+, a breakthrough method to mass-produce and test thousands of antibodies.
SurvivorNet on MSN
Cancer patients are living longer — a closer look at the treatments driving this progress
New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...
Canadian researchers say a blood test measuring immune response to gut bacteria could help predict Crohn’s disease years ...
A simple blood test can predict who will suffer from a debilitating bowel disease later in life, paving the way for early ...
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a pioneering certified biotechnology ...
At the Panacea Biotec office, conversations around DengiAll are cloaked with an air of eagerness. With the human trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback